GLAXOSMITHKLINE BIOLOGICALS SA
531Patents
493Active
531Granted
60Portfolio score
Filing activity: Mar 7, 2000 → Feb 13, 2024 · 98 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9801897B2 | Delivery of RNA to trigger multiple immune pathways | Chemistry; Metallurgy | 67 | Active |
| US9770463B2 | Delivery of RNA to different cell types | Chemistry; Metallurgy | 66 | Active |
| US10487332B2 | Immunisation of large mammals with low doses of RNA | Chemistry; Metallurgy | 58 | Active |
| US10532067B2 | Delivery of RNA to trigger multiple immune pathways | Chemistry; Metallurgy | 58 | Active |
| US11026964B2 | Delivery of RNA to different cell types | Chemistry; Metallurgy | 46 | Active |
| US11058762B2 | Immunogenic compositions and uses thereof | Emerging Cross-Sectional Technologies | 42 | Active |
| US11291682B2 | Delivery of RNA to trigger multiple immune pathways | Chemistry; Metallurgy | 42 | Active |
| US11291635B2 | Virion-like delivery particles for self-replicating RNA molecules | Emerging Cross-Sectional Technologies | 41 | Active |
| US11078237B2 | Antigen delivery platforms | Chemistry; Metallurgy | 37 | Active |
| US8563002B2 | Recombinant RSV antigens | Emerging Cross-Sectional Technologies | 36 | Active |
| US10238733B2 | Cationic oil-in-water emulsions | Emerging Cross-Sectional Technologies | 36 | Active |
| US11324770B2 | Delivery of RNA to trigger multiple immune pathways | Chemistry; Metallurgy | 36 | Active |
| US7628995B2 | Outer membrane vesicles and uses thereof | Chemistry; Metallurgy | 29 | Expired |
| US9249196B2 | Neisseria meningitidis antigens and compositions | Emerging Cross-Sectional Technologies | 29 | Active |
| US7252308B2 | Connector device for the sterile connection of tubes | Emerging Cross-Sectional Technologies | 26 | Expired |
| USD485365S1 | Vial | General | 26 | Expired |
| US8703148B2 | Immunogenic composition | Emerging Cross-Sectional Technologies | 25 | Active |
| US9655845B2 | Oil-in-water emulsions that contain nucleic acids | Emerging Cross-Sectional Technologies | 24 | Active |
| US7927858B2 | Drying process | Emerging Cross-Sectional Technologies | 24 | Expired |
| US8753645B2 | Conjugation process of bacterial polysaccharides to carrier proteins | Human Necessities | 24 | Active |
| US7612173B2 | Vaccine for prevention and treatment of HIV-infection | Chemistry; Metallurgy | 23 | Expired |
| US8846080B2 | Vaccine | Chemistry; Metallurgy | 23 | Active |
| US10307374B2 | Oil-in-water emulsions that contain nucleic acids | Emerging Cross-Sectional Technologies | 22 | Active |
| US11135287B2 | Method for preparing composition comprising a cationic oil-in-water emulsion | Emerging Cross-Sectional Technologies | 22 | Active |
| US11026890B2 | Oil-in-water emulsions that contain nucleic acids | Emerging Cross-Sectional Technologies | 22 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.